Concepedia

Indrani Sarkar

IS

Statistics

Publications

27

Citations

2K

H-Index

19

Active since

2007

Affiliations

North Bengal University(Current)

Yale Cancer Center

Dana-Farber Cancer Institute

Institut Gustave Roussy

Massachusetts General Hospital

Indrani Sarkar is an author at North Bengal University specializing in pharmacology, oncology, and life sciences.

ORCID

Publications per year

2007–2021

27

Publications

27

Long-term Clinical Outcomes and Biomarker Analyses of Atezolizumab Therapy for Patients With Metastatic Triple-Negative Breast Cancer

Leisha A. Emens, Cristina Cruz, Joseph P. Eder et al. · JAMA Oncology · 2018 · 793 citations · Full text

, , +17

HIV-1 Proviral DNA Excision Using an Evolved Recombinase

Indrani Sarkar, Ilona Hauber, Joachim Hauber et al. · Science · 2007 · 211 citations

, , +17

Safety, clinical activity and biomarker assessments of atezolizumab from a Phase I study in advanced/recurrent ovarian and uterine cancers

Joyce F. Liu, Michael S. Gordon, Jennifer Veneris et al. · Gynecologic Oncology · 2019 · 137 citations

, , +14

Safety and clinical activity of atezolizumab in head and neck cancer: results from a phase I trial

A. Dimitrios Colevas, Rastislav Bahleda, Fadi Braiteh et al. · Annals of Oncology · 2018 · 132 citations · Full text

, , +15

Safety, Clinical Activity, and Biological Correlates of Response in Patients with Metastatic Melanoma: Results from a Phase I Trial of Atezolizumab

Omid Hamid, Luciana Molinero, Christopher R. Bolen et al. · Clinical Cancer Research · 2019 · 82 citations

, , +17

1–5 of 27